Literature DB >> 12862107

Acceptance of hepatitis B vaccine by workers in a Nigerian teaching hospital.

A O Fatusi1, O A Fatusi, A O Esimai, A A Onayade, O S Ojo.   

Abstract

OBJECTIVES: To determine the pattern of vaccine uptake by hospital personnel in a specifically designed pioneer hepatitis B vaccination programme and to highlight major lessons for ensuring success in future programmes.
DESIGN: A review of vaccination and employment records for a forty four-month period and comparative analysis on the basis of professional grouping and work units.
SETTING: Obafemi Awolowo University Teaching Hospital Complex, Ile-Ife, Nigeria.
SUBJECTS: A total of 2,548 employees of the teaching hospital that have worked for a minimum of one year on a continuous basis between April 1992 and December 1995.
INTERVENTIONS: Procurement of recombinant hepatitis B vaccine (Engerix, SmithKline Beecham) by the hospital management and provision of the same to all interested employees of the teaching hospital at no cost under a vaccination programme which was conducted on an on-site basis. MAIN OUTCOME MEASURES: 'Participation' in the vaccination programme was defined as the uptake of at least one dose of hepatitis B vaccine, and 'compliance' defined as the receipt of the three prescribed doses of the hepatitis B vaccine.
RESULTS: The level of participation in the vaccination programme was high with 91.9% of the target population of hospital workers receiving at least a dose of the vaccine, while only about half (53.8%) of the group complied with receiving the required three doses of the vaccine. In terms of participation, by professional grouping, laboratory workers and nurses recorded the lowest rates (82.5% and 84% respectively), while 100% participation was recorded in respect of the staff of engineering, medical records, pharmacy and physiotherapy departments. The highest rate of compliance (receipt of three doses) was also found among non-clinical workers (medical record personnel--76.3% and engineering staff--69.5%) while the lowest rate was found among nurses (39.7%) and doctors (40.3%).
CONCLUSION: Workers with the highest possibility of knowledge of, and exposure to hepatitis B infection within the hospital setting--doctors, nurses, and laboratory workers--showed the greatest apathy to the vaccination programme. Reasons for this trend demand close examination, and subsequently, identification of specific action that needs to be taken to improve the uptake of the vaccine by the target population, particularly the high-risk groups, in future programmes. Among others, targeting all groups of workers with appropriate education on the infection; active involvement of professional groups in the planning and execution of the vaccination programme; and review of the implementation logistics are some of the key points to note for future programmes.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 12862107     DOI: 10.4314/eamj.v77i11.46734

Source DB:  PubMed          Journal:  East Afr Med J        ISSN: 0012-835X


  19 in total

1.  Hepatitis B virus vaccination compliance among health care workers in intensive care unit: necessity to improve protection of attending physicians.

Authors:  B R Panhotra; A K Saxena; A S Al-Mulhim
Journal:  Intensive Care Med       Date:  2005-09-10       Impact factor: 17.440

2.  HEPATITIS B VACCINATION STATUS AND NEEDLE STICK INJURY EXPOSURE AMONG OPERATING ROOM STAFF IN LAGOS, NIGERIA.

Authors:  J O Olatosi; N C Anaegbu
Journal:  J West Afr Coll Surg       Date:  2016 Jan-Mar

3.  Knowledge of Hepatitis B Virus Infection, Immunization with Hepatitis B Vaccine, Risk Perception, and Challenges to Control Hepatitis among Hospital Workers in a Nigerian Tertiary Hospital.

Authors:  Olusegun Adekanle; Dennis A Ndububa; Samuel Anu Olowookere; Oluwasegun Ijarotimi; Kayode Thaddeus Ijadunola
Journal:  Hepat Res Treat       Date:  2015-01-22

4.  Hepatitis B vaccination coverage, knowledge and sociodemographic determinants of uptake in high risk public safety workers in Kaduna State, Nigeria: a cross sectional survey.

Authors:  Chinwe Lucia Ochu; Caryl M Beynon
Journal:  BMJ Open       Date:  2017-06-02       Impact factor: 2.692

5.  Long-term persistence of seroprotection by hepatitis B vaccination in healthcare workers of southern Italy.

Authors:  Giuseppe Grosso; Antonio Mistretta; Stefano Marventano; Roberta Ferranti; Luisa Mauro; Rosario Cunsolo; Lidia Proietti; Mariano Malaguarnera
Journal:  Hepat Mon       Date:  2012-09-04       Impact factor: 0.660

6.  Hepatitis-B vaccination status among dental surgeons in benin city, Nigeria.

Authors:  Cc Azodo; Ao Ehizele; I Uche; P Erhabor
Journal:  Ann Med Health Sci Res       Date:  2012-01

7.  Meningococcal, influenza virus, and hepatitis B virus vaccination coverage level among health care workers in Hajj.

Authors:  Tariq A Madani; Tawfik M Ghabrah
Journal:  BMC Infect Dis       Date:  2007-07-18       Impact factor: 3.090

8.  Hepatitis B Awareness and Vaccination Patterns among Healthcare Workers in Africa.

Authors:  Shemal M Shah; Holly Rodin; Hope Pogemiller; Oluwadayo Magbagbeola; Kenneth Ssebambulidde; Anteneh Zewde; Matthew Goers; Benjamin Katz; Itegbemie Obaitan; Ehab Fawzy Abdo; Sahar Mohamed Hassany; Mohamed Elbadry; Abdelmajeed Mahmoud Moussa; Jasintha Mtengezo; Mark Dedzoe; Benjamin Henkle; Martha Binta Bah; Matthew Sabongi; Johnstone Kayandabila; Robert Fell; Ifeorah Ijeoma; Lucy Ochola; Mirghani Yousif; Jose D Debes
Journal:  Am J Trop Med Hyg       Date:  2020-10-01       Impact factor: 3.707

9.  Compliance with hepatitis B vaccination among adult males with sexually transmitted infections.

Authors:  Jamshid Ayatollahi; Ali Ayatollahi; Reza Ayatollahi; Ali Mellat Ardekani; Seyed Hossein Shahcheraghi
Journal:  Jundishapur J Microbiol       Date:  2014-07-01       Impact factor: 0.747

10.  Medical and dental students' attitude and practice of prevention strategies against hepatitis B virus infection in a Nigerian university.

Authors:  Oyebimpe Jumoke Adenlewo; Peter Olalekan Adeosun; Olawunmi Adedoyin Fatusi
Journal:  Pan Afr Med J       Date:  2017-09-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.